NCT05489211 2026-03-19
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
AstraZeneca
Phase 2 Recruiting
AstraZeneca
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Jazz Pharmaceuticals
National Cancer Institute (NCI)